Filing Flows › Roivant Sciences (ROIV) › Q1 FY27 › vs Q4 FY26
Roivant Sciences (ROIV) Q1 FY27 vs Q4 FY26 (quarter over quarter)
Roivant Sciences's revenue fell $1.1M (-43%) from $2.5M in Q4 FY26 to $1.4M in Q1 FY27.
Roivant Sciences, Q1 FY27: revenue $1.4M (-34% year over year), net loss $291M, operating cash flow −$271M. The chart draws each line against Q4 FY26, the increases inside each band.
Every line
| Line | Q1 FY27 | Q4 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $1.4M | $2.5M | −$1.1M | -43% |
| Other income, net | $71.4M | $38.9M | $32.6M | +84% |
| Income tax benefit | $4.0M | −$98.4M | $102M | — |
| Net loss | $291M | −$356M | $646M | — |
| Costs & expenses | $367M | $41.4M | $326M | +788% |
| Operating costs | $367M | −$413M | $780M | — |
| Operating cash sources | $354M | $242M | $113M | +47% |
| Depreciation & amortization | $600K | $638K | −$38K | -6% |
| Share-based compensation | $83.3M | $77.2M | $6.2M | +8% |
| Cash used in operations | $271M | $164M | $107M | +65% |
| Net loss absorbed | $291M | −$356M | $646M | — |
| Working capital & other | $63.8M | $597M | −$534M | -89% |
Questions
How much did Roivant Sciences's revenue grow quarter over quarter in Q1 FY27?
Roivant Sciences's revenue fell $1.1M (-43%) from $2.5M in Q4 FY26 to $1.4M in Q1 FY27.